SLIDE 1
OUTLINE
- The study
- The sample
- The findings
- The session
OUTLINE The study The sample The findings The session - - PowerPoint PPT Presentation
OUTLINE The study The sample The findings The session - - PowerPoint PPT Presentation
OUTLINE The study The sample The findings The session Conflict of interest: I have no conflict of interest to declare. THE STUDY 2 year study (2013-2015) Funded by CIHR Conducted in the national capital
SLIDE 2
SLIDE 3
THE STUDY
- 2 year study (2013-2015)
- Funded by CIHR
- Conducted in the national capital area
- Qualitative study (grounded theory)
- Lots of research on treatment adherence
- Very little research on the experience of side effects
- Goal : gain a better understanding of the experience of side effects
- Interviews
- Describe the experience with treatment
- Describe the experience with side effects
- Explain what it means to live with side effects
SLIDE 4
THE SAMPLE
- On average, participants were born between 1960 and 1969 (66%).
- Most of the participants were male (74%).
- The vast majority of participants had an annual income below $30,000 (86%).
- 50% of the participants had a college or university degree.
SLIDE 5
THE SAMPLE
- Year of diagnosis and first treatment were distributed as such within the group
SLIDE 6
THE SAMPLE
- Total side effects experienced
SLIDE 7
THE FINDINGS
SLIDE 8
THE SIDE EFFECTS
- Context
- Historical context
- Treatment context
- Types
- Immediate – Progressive
- Transient – Permanent
- Hidden – Visible
- Minor – Severe
- Nature
- Unpredictable
- Unstable
- Highly individual
SLIDE 9
THE EXPERIENCE
- Becoming with
- Becoming sick and healthy
- Becoming another version of yourself
- Becoming a new “normal”
- Living with
- Living with “powerful drugs in your system”
- Living with uncertainties
- Living with limitations
- Dealing with
- Dealing with the side effects
- Dealing with the treatment
- Dealing with the physician
SLIDE 10
THE CONNECTIONS
- People
- Medical specialists
- Specialized health care providers
- Peers
- Things
- Drugs
- Devices
- Objects
- Systems
- Knowledge systems (dominant and alternative)
- Health care system
- Welfare system
SLIDE 11
THE FINDINGS
marilou.gagnon@uottawa.ca Instagram: ml_gagnon
SLIDE 12
THE SESSION
Goal: talk about side effects, medications errors, drug interactions and polypharmacy
- Michelle Foisy (Northern Alberta HIV Program)
- Addressing medication errors in HIV-positive patients
- Alice Tseng (University Health Network)
- Increase INR after switching from Atazanovir/Ritonavir to Darunavir/Cobicistat in a
patient on Warfarin: Boosters are not always equal
- Jam Bravo (University Health Network)
- Successful use of potent enzyme inducer enzalutamide in a treatment-experienced HIV-
positive male with prostate cancer
- Denise Kreutzwiser (University of Toronto)
- Drug therapy problems in complex HIV/AIDS patients: identification and management by